Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Boehringer Ingelheim
US Department of Justice

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 8,933,097 protect, and when does it expire?

Patent ► Subscribe protects CHILDREN'S ALLEGRA ALLERGY and CHILDREN'S ALLEGRA HIVES and is included in one NDA.

This patent has thirty-eight patent family members in thirty-six countries.

Summary for Patent: ► Subscribe

Title:Fexofenadine suspension formulation
Abstract: The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.
Inventor(s): Chrzan; Kazimierz (New Hope, PA), Haribhakti; Rajiv (Churchville, PA), Mermey; Matthew (Leawood, KS), Porcello; Curtis J. (Ewing, NJ), Silvey; Gary Lee (Overland Park, KS), Tran; Vinh (Leawood, KS), Agrawala; Prafulla (Kendall Park, NJ)
Assignee: Sanofi-Aventis U.S. LLC (Bridgewater, NJ)
Application Number:12/138,468
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis Us
fexofenadine hydrochloride
SUSPENSION;ORAL201373-001Jan 24, 2011OTCYesYes► Subscribe► SubscribeY
Sanofi Aventis Us
fexofenadine hydrochloride
SUSPENSION;ORAL201373-002Jan 24, 2011OTCYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina058323► Subscribe
Austria431137► Subscribe
Australia2006326551► Subscribe
BrazilPI0619895► Subscribe
Canada2633086► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus